SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950103-17-002872
Filing Date
2017-03-28
Accepted
2017-03-28 17:29:14
Documents
2
Period of Report
2017-03-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp74416_8k.htm 8-K 17359
2 EXHIBIT 10.1 dp74416_ex1001.htm EX-10.1 1790512
  Complete submission text file 0000950103-17-002872.txt   1809220
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 17719965
SIC: 2834 Pharmaceutical Preparations